ZeOmega competitorsClear all

ZeOmega's top competitors include PatientsLikeMe, Independa, NovoCure and Oncimmune.
ZeOmega
ZeOmega
Develops a population health management program that enables payers and care-delivery organizations to improve individual health and provider performance by integrating workflow, analytics, content and communication capabilities. This facilitates collaboration among healthcare stakeholders payers, providers and value-based healthcare organizations.
PatientsLikeMe
PatientsLikeMe
PatientsLikeMe is an online community that allows patients with life-altering diseases to communicate and share with one another.
Independa
Independa
Independa is a subscription services platform offering technology-enabled, independent-living solutions for the elderly.
NovoCure
NovoCure
NovoCure engages in the development, manufacture and commercialization of tumor treating fields for the treatment of solid tumors.
Oncimmune
Oncimmune
Leader in early cancer detection
Founding Date
Founding Date
2001
Founding Date
2004
Founding Date
2009
Founding Date
2000
Founding Date
2006
Type
Type
Private
Type
Private
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Plano, US HQ
Bengaluru, IN
Bellevue, US
Locations
Cambridge, US HQ
Locations
San Diego, US HQ
Locations
Jersey, JE HQ
München, DE
Haifa, IL
Chiyoda City, JP
Root D, CH
Dover, GB
Atlanta, US
see more
Locations
Nottingham, GB HQ
Dortmund, DE
De Soto, US
Employees
Employees
5141% increase
Employees
981% increase
Employees
56
Employees
59821% increase
Employees
582% increase
Twitter followers
Twitter followers
569
Twitter followers
31.6 k
Twitter followers
2.1 k
Twitter followers
1.4 k
Twitter followers
4.3 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
38
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
26
Number of tweets (last 30 days)
15
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.4
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3.8
Average likes per tweet (last 30 days)
3.5
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
94.74%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
363706
Alexa Website Rank
133241
Alexa Website Rank
1435350
Alexa Website Rank
296524
Alexa Website Rank
474059

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$248.1m (FY, 2018)
Revenue (est.)
£104k (FY, 2018)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$80m (FY, 2018)
Cost of goods
£258k (FY, 2018)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
$168m (FY, 2018)
Gross profit
(£154k) (FY, 2018)
Net income
Net income
N/A
Net income
N/A
Net income
N/A
Net income
($63.6m) (FY, 2018)
Net income
(£5m) (FY, 2018)

Funding

Latest funding round
Latest funding round
$ 21.5m (about 6 years ago)
Latest funding round
$ 100m (almost 3 years ago)
Latest funding round
$ 6m (over 4 years ago)
Latest funding round
N/A
Latest funding round
$ 15m (almost 3 years ago)
Total funding raised
Total funding raised
$ 21.5m
Total funding raised
$ 125.5m
Total funding raised
$ 18.7m
Total funding raised
$ 116m
Total funding raised
$ 15m
For sources of this data, please see the company profile

View company profiles

PatientsLikeMe
HQ
Cambridge, US
Employees
98↑ 1% increase

PatientsLikeMe is an online community that allows patients with life-altering diseases to communicate and share with one another.

View company
Independa
HQ
San Diego, US
Employees
56

Independa is a subscription services platform offering technology-enabled, independent-living solutions for the elderly.

View company
NovoCure
HQ
Jersey, JE
Employees
598↑ 21% increase

NovoCure engages in the development, manufacture and commercialization of tumor treating fields for the treatment of solid tumors.

View company
Oncimmune
HQ
Nottingham, GB
Employees
58↑ 2% increase

Leader in early cancer detection

View company